Philippe Mendels-Flandre, AUSTRAL Dx CEO

Created in 2021, Austral Dx is a deeptech startup which transforms the diagnosis of cardio-pulmonary diseases with a contactless, non-invasive, AI-powered medical device providing a precise and reliable result in less than 3 minutes.

The startup is finalizing its seed round of €1.5m, with over €1m already secured from a VC, to accelerate its development. Austral Dx is opening its capital to all private investors who are sensitive to public health issues and are looking to give more meaning to their investments.
For more information:  https://capitalcell.com/fr/campaign/australdx/